Back to search
FDAFDA · Food and drugs·Recall number D-1288-2022

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856179, NDC 43598-561-78

Published August 3, 2022 · Recall initiated: July 13, 2022

Summary

FDA records drug Class II recall D-1288-2022, published August 3, 2022 and initiated July 13, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 2,639 cartons; Lot: Lot T2100515, Exp 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

FAILED DISSOLUTION SPECIFICATIONS

What to do

Voluntary: Firm initiated · Letter

Get an email if LANSOPRAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LANSOPRAZOLE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA
Lot
Lot T2100515, Exp 01/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856179, NDC 43598-561-78 recalled?

Yes. FDA published recall D-1288-2022 on August 3, 2022. Reported hazard: FAILED DISSOLUTION SPECIFICATIONS

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LANSOPRAZOLE.